GlassScriptPhysician profile
Daniel J Bodmer
NPI 1023462975
$3,913.26
in general payments reported to CMS, 2019-2025
26 companies · $1,033 in 2025
The $1,033 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $631 · 2023: $170 · 2024: $2,079 · 2025: $1,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,459 · Travel and Lodging: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,458.65 |
| Travel and Lodging | $823.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $1,530.10 | 2024-2025 | Peripheral Vascular, Asahi Interventional Radiology Wires |
| Medtronic, INC. | $630.64 | 2022 | |
| Sumitomo Pharma America, INC. | $403.08 | 2024-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $175.37 | 2024-2025 | |
| Janssen Biotech, INC. | $135.54 | 2025 | Erleada |
| Terumo Medical Corporation | $107.38 | 2023-2024 | Azur Cx Detachable, Glidewire, Navicross |
| Novartis Pharmaceuticals Corporation | $100.10 | 2024-2025 | |
| Baxter Healthcare | $94.53 | 2024 | Tisseel |
| Accord Healthcare, INC. | $81.46 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $73.99 | 2023 | Embozene |
| Tolmar, INC. | $71.33 | 2024-2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $71.01 | 2025 | |
| Tempus Ai, INC | $59.00 | 2024 | Xt Cdx |
| Philips North America LLC | $50.21 | 2025 | Disease Management Solutions Equipment Undivided |
| Vertex Pharmaceuticals Incorporated | $45.01 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $41.54 | 2025 | |
| Boston Scientific Corporation | $36.03 | 2025 | Ams 800 Artificial Urinary Sphincter |
| Sun Pharmaceutical Industries INC. | $34.39 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $30.38 | 2024 | Provenge |
| Merck Sharp & Dohme LLC | $28.25 | 2024 | Keytruda |
| Steris Corporation | $25.21 | 2024 | |
| Progenics Pharmaceuticals, INC. | $19.73 | 2024 | |
| Endo USA, INC. | $18.53 | 2024 | Aveed, Xiaflex |
| Teleflex LLC | $17.05 | 2024 | Solesta |
| Calyxo, INC. | $17.05 | 2025 | Cvac Aspiration System |
| Olympus America INC. | $16.35 | 2023 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bodmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.